Tangeretin Reduces Ultraviolet B (UVB)-induced Cyclooxygenase-2 Expression in Mouse Epidermal Cells by Blocking Mitogen-activated Protein Kinase (MAPK) Activation and Reactive Oxygen Species (ROS) Generation
Overview
Nutritional Sciences
Affiliations
The present study examined the effects of tangeretin, a polymethoxylated flavonone present in citrus fruits, on ultraviolet B (UVB)-induced cyclooxygenase-2 (COX-2) expression in JB6 P+ mouse skin epidermal cells. Tangeretin suppressed UVB-induced COX-2 expression and transactivation of nuclear factor-κB and activator protein-1 in JB6 P+ cells. Moreover, tangeretin blocked UVB-induced phosphorylation of Akt and mitogen-activated protein kinases (MAPKs), including extracellular signal-regulated protein kinase, c-Jun N-terminal kinase, and p38, and attenuated the phosphorylation of MAPK kinases 1/2, 3/6, and 4. Tangeretin also limited the endogenous generation of reactive oxygen species (ROS), thereby protecting the cells against oxidative stress. However, tangeretin did not scavenge the stable 1,1-diphenyl-2-picrylhydrazyl (DPPH) radical and influence the nicotinamide adenine dinucleotide phosphate oxidase activity. These results suggest that the anti-inflammatory effects of tangeretin stem from its modulation of cell signaling and suppression of intracellular ROS generation. Tangeretin may have a potent chemopreventive effect in skin cancer.
Recovery, Bioactivity, and Utilization of Bioactive Phenolic Compounds in Peel.
Durmus N, Gulsunoglu-Konuskan Z, Kilic-Akyilmaz M Food Sci Nutr. 2024; 12(12):9974-9997.
PMID: 39723030 PMC: 11666827. DOI: 10.1002/fsn3.4570.
Wani I, Koppula S, Balda A, Thekkekkara D, Jamadagni A, Walse P Life (Basel). 2024; 14(4).
PMID: 38672774 PMC: 11051149. DOI: 10.3390/life14040504.
Wang F, Shin J, Kang E, Kim J, Jang S, Cho B Heliyon. 2023; 9(12):e22804.
PMID: 38090015 PMC: 10711179. DOI: 10.1016/j.heliyon.2023.e22804.
Anticancer Potential of Flavonoids: An Overview with an Emphasis on Tangeretin.
de Luna F, Ferreira W, Casseb S, de Oliveira E Pharmaceuticals (Basel). 2023; 16(9).
PMID: 37765037 PMC: 10537037. DOI: 10.3390/ph16091229.
Hermawan A, Putri H, Hanif N, Ikawati M Evid Based Complement Alternat Med. 2021; 2021:2234554.
PMID: 34335799 PMC: 8294962. DOI: 10.1155/2021/2234554.